Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  St. Jude Medical, Inc.    STJ

SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

St. Jude Medical, Inc. : St Jude To Stop Selling Another Version Of Defibrillator Wires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/04/2012 | 09:48am EST

St. Jude Medical Inc. (STJ) will stop selling another version of its defibrillator wires in an effort to head off potential problems like those the medical-device maker is currently battling with its Riata and Riata ST wires.

The Riata defibrillator wires, called leads, are no longer on the market but are still implanted in thousands of patients in the U.S. In a medical journal last month, prominent cardiologist Robert G. Hauser wrote that the cables are responsible for at least 20 deaths.

Wednesday, the company said it will cease selling its QuickSite and QuickFlex left-ventricular leads used to connect cardiac resynchronization therapy devices to the heart. Roughly 171,000 QuickSite and QuickFlex leads have been sold worldwide.

The decision comes as St. Jude has confirmed 39 cases of the metal wires wearing through their silicone covering, leading to an incidence rate of 2.3 in every 10,000 leads. Still, it stressed that its decision to stop selling the wires is a proactive one.

"It is important to note, however, that the overall safety and reliability of QuickSite and QuickFlex leads continues to be comparable to currently available CRT leads from other manufacturers," the company wrote.

The wire leads connect life-saving medical devices, which are placed under the skin in the shoulder area, to the heart and delivers a jolt that restores proper rhythm. Because of the constant pounding motion of the heart, the thin leads can be damaged.

Shares closed Tuesday at $43.80 and were inactive in premarket trading. The stock is up roughly 36% from lows hit late last year when the Food and Drug Administration termed the Riata defibrillator issues as a Class I recall, which applies to grave dangers like chance of death.

 
   -By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ST. JUDE MEDICAL, INC.
02/16 ST JUDE MEDICAL : Patent Issued for Ablation System, Methods, and Controllers (U..
02/16 ST JUDE MEDICAL : Patent Issued for System and Method for Rendering an Image of ..
02/10 ABBOTT LABORATORIES : Labs halts use of HeartMate PHP blood pump after death, ma..
02/09 ST JUDE MEDICAL : An Application for the Trademark "CENTRIMAG" Has Been Filed by..
02/09 ST JUDE MEDICAL : Patent Issued for Leaflet in Configuration for Function in Var..
02/08 ST JUDE MEDICAL : Justification and Approval - 65-- Consignment St Jude Medical ..
02/03 ST JUDE MEDICAL : Medical Device Manufacturers Face A Cybersecurity Heartache
02/02 ST JUDE MEDICAL : Patent Issued for System and Method for Correction of Inhomoge..
02/02 ST JUDE MEDICAL : Patent Issued for Pneumatically Power-Assisted Tavi Delivery S..
02/02 St. Jude Medical MRI-safe pacemaker gets long-awaited FDA approval
More news
Sector news : Medical Devices & Implants
02/16 STRAUMANN : on hunt for 3D printer partner, could take stake - CEO
02/09 Smith & Nephew hurt by tough markets in China and Gulf states
02/02DJBECTON DICKINSON AND : Earnings Jump, and It Raises 2017 Outlook
02/01DJBAXTER INTERNATIONAL : Profit Climbs 19%
01/31DJZIMMER BIOMET : Hip, Knee Businesses Drive Results
More sector news : Medical Devices & Implants
News from SeekingAlpha
02/17 GLAZER CAPITAL : Merger Arbitrage With Convertibles - A Lower Risk Alternative
02/15 Panel To Stand Sentinel Over Embolic Filter
02/01 Dividend Champions For February 2017
01/25 U.S. Medtech Approvals Dip, But Could Pick Up In 2017
01/11 Medtech Mergers And Acquisitions Regresses To The Mean In 2016
Advertisement
Financials ($)
More Financials
Chart ST. JUDE MEDICAL, INC.
Duration : Period :
St. Jude Medical, Inc. Technical Analysis Chart | STJ | US7908491035 | 4-Traders
Full-screen chart
Technical analysis trends ST. JUDE MEDICAL,...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael T. Rousseau President, Chief Executive Officer & Director
Daniel J. Starks Executive Chairman
Scott P. Thome Vice President-Global Operations & Supply Chain
Donald J. Zurbay Chief Financial Officer & Vice President
Mark D. Carlson Chief Medical Officer & VP-Global Clinical Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ST. JUDE MEDICAL, INC.0.79%0
STRYKER CORPORATION5.45%47 109
SMITH & NEPHEW PLC-1.47%13 160
WRIGHT MEDICAL GROUP N..17.32%2 785
GLAUKOS CORP33.00%1 531
OSSTEM IMPLANT CO LTD--.--%779
More Results